Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris

PHASE4CompletedINTERVENTIONAL
Enrollment

1,032

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

December 31, 2005

Conditions
Psoriasis Vulgaris
Interventions
DRUG

Calcipotriol, (calcipotriol + betamethasone)

Trial Locations (7)

6532

Canisius-Wilhelmina Ziekenhuis, Nijmegen

9000

Universitair Ziekenhuis, Ghent

42055

Hôpital Nord, Service de Dermatologie, Saint-Etienne

60590

Klinikum der Goethe-Universität, Zentrum für Dermatologie und Venerologie, Frankfurt

L8N 1V6

Dermatrials Research Dermatology Centre, Hamilton

08221

Hospital Mutua de Terrassa Dermatology Service, Terrassa

L63 4JY

Clatterbridge Hospital, Department of Dermatology, Merseyside

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT00216892 - Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris | Biotech Hunter | Biotech Hunter